61
Views
6
CrossRef citations to date
0
Altmetric
Review

Clinical use of parnaparin in major and minor orthopedic sugery: a review

, , &
Pages 983-990 | Published online: 10 Oct 2008

References

  • Antiplatelet Trialists’ Collaboration1994Collaborative overview of randomised trials of antiplatelet therapy III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patientsBMJ308235468054013
  • ArcelusJIKudrnaJCCapriniJA2006Venous thromboembolism following major orthopedic surgery: what is the risk after discharge?Orthopedics295061616786943
  • BandieraSCasaliniDFriemelP2003Clinical experience with parnaparin in orthopedic sugeryEur Bull Drug Res117791
  • BellostaRFerrariPLuzzaniL2007Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrationsAngiology583162217626986
  • CalabroAPiarulliFMilanD1993Clinical assessment of low molecular weight heparin effects in peripheral vascular diseaseAngiology44188958382899
  • ChiapuzzoEOrengoGBOttridaG1988The use of low molecular weight heparins for postsugical deep vein thrombosis prevention in orthopedic patientsJ Int Med Res16359663197913
  • CollinsRScrimgeourAYusufS1988Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgeryN Engl J Med3181162733283548
  • ColwellCWJrSpiroTETrowbridgeAA1994Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safetyJ Bone Joint Surg Am763148288662
  • CorradoFFiniMSeveriniG1989Low molecular weight heparin (Fluxum) prevention of post-operative thrombosis in urological surgery: a controlled studyClin Trials J2613848
  • CullisonTRMuldoonMPGormanJD1996The incidence of deep venous thrombosis in anterior cruciate ligament reconstructionArthroscopy1265799115551
  • DeasaiPSukM2007Orthopedic trauma in pregnancyAm J Orthop36E160618075614
  • DelisKTHuntNStrachanRK2001Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopyThromb Haemost868172111583313
  • Della MarchinaMRenziGRenziC1993Low molecular weight heparins in chronic venous insufficiency: controlled trial of parnaparin efficacy and tolerabilityBrit J Clin Res42936
  • DemersCMarcouxSGinsbergJS1998Incidence of venographically proved deep vein thrombosis after knee arthroscopyArch Intern Med15847509437378
  • Di StefanoFGiglioAVinciM1988Low molecular weight heparins prevention of post-operative deep vein thrombosis in vascular surgeryPharmatherapeutica526153174726
  • DuricaSS1997Venous thromboembolism in the cancer patientCurr Opin Hematol4306119288462
  • EynonAMJamesSLeachP2004Thromboembolic events after arthroscopic knee surgeryArthroscopy20Suppl 2233415243419
  • FitzgeraldRHJrSpiroTETrowbridgeAA2001Prevention of venous thromboembolic disease following primary total knee arthroplasty. A erandomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarinJ Bone Joint Surg Am83A900611407799
  • ForestierFDaffosFCapella-PavlovskyM1984Low molecular weight heparin (PK10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasoundThromb Res34557606740572
  • ForestieriPQuartoGDe CaterinaM2007Prophylaxis of thromboembolism in bariatric surgery with parnaparinObes Surg1715586218004632
  • FreedmanKBBrookenthalKRFitzgeraldRHJr2000A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplastyJ Bone Joint Surg Am82-A9293810901307
  • GeertsWHHeitJAClagettP2001Prevention of venous thromboembolismChest119S132S75
  • GeertsWHPineoGFHeitJA2004Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thromblytic therapyChest126338S400S15383478
  • German Hip Arthroplasty Trial (GHAT) Group1992Prevention of deep vein thrombosis with low molecular weight heparin in patients undergoing total hip replacement. A randomized trialArch Orthop Trauma Surg111110201314065
  • GoldhaberSZ2004Pulmonary embolismLancet363129530515094276
  • HaasSBreyerHGBacherHP2006Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular weight heparin with unfractioned heparin (ECHOS Trial)Int Angiol253354217164738
  • HollandKSchainFH1995Prevention of thrombosis with fraxiparin 0.3 after arthroscopic interventionsFortschr Med11333567557810
  • HullRDPineoGFFrancisC2000Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hup arthroplasty patients: a double-blind, randomized comparisonArch Intern Med160219920710904464
  • HullRDPineoGFSteinPD2001Timing of initial administration of low molecular weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a Systematic reviewArch Int Med16119526011525697
  • ImperialeTFSperoffT1994A meta-analysis of methods to prevent venous thromboembolism following total hip replacementJAMA271178057515115
  • JuareguitoJWGreenwaldAEWilcoxJF1999The incdence of deep venous thrombosis after arthroscopic knee surgeryAm J Sports Med277071010569354
  • KochAZieglerSBreitschwerdtH2001Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient dataThromb Res10229530911369423
  • LaguardiaAMCaroliGC1992Prevention of deep vein thrombosis in orthopaedic surgery. Comparison of two different treatment protocols with low molecular weight heparin (Fluxum)Curr Med Res Opin12584931316259
  • LecompteTLuoSKStieltjesN1991CorrespondenceLancet3381217
  • LudwigRJAlbanSBistrianR2006The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on blood borne metastasis in vivoThrom Haemost9553540
  • MangialardiNMatteoniRSerraoE1991Medium term treatment of thrombotic pathologies of the lower limbs with a new LMW heparinMed Prax1217
  • MannarinoEPasqualiniLInnocenteS1991Efficacy of low-molecular-weight heparin in the management of intermittent claudicationAngiology42171847026
  • MartinesGRestoriG1990Estimation of the dose-effect relationship of a low molecular weight heparin (Fluxum) through meta-analysis of clinical dataInt Rev Clin Sci27990
  • MascaliFCondorelliASalanitriG1988Post-surgery thrombo-embolism prevention by LMW heparin subcutaneous administrationEur Rev Med Pharmacol Sci1013541
  • MaugeriNDe GaetanoGBarbantiM2005Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparinHaematologica90833915951297
  • MaugeriNDi FabioGBarbantiM2007Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole bloodThromb Haemost979657317549299
  • McKeageKKeatingGM2008Parnaparin: a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disordersDrugs681052218081375
  • MelandriGSempriniFCerviV1993Benefit of adding low molecular weight heparin tot he conventional treatment of stable angina pectoris: a double-blind, randomized, placebo-controlled trialCirculation882517238252662
  • MichotMConenDHoltzD2002Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxix with low-molecular weight heparinArthroscopy182576311877611
  • MilaniMRPalazziniE1990Neutralization of fluxum, a low molecular weight heparin, by protamineInt Rev Med Sc2459
  • MohrVDLenzJ1991Heparin-assoziierte thrombocytopenie, thrombose und embolie. Unerwunschte wirkung der thromboembolieprophylaxe mit dem niedermolekularen heparin enoxaparinChirurg62686901660803
  • MontebugnoliMBugamelliSZangheriE2007Prophylaxis of venous thromboembolism in minor orthopedic surgery with parnaparinClin Appl Thromb Hemost132495817636187
  • Navarro-SanzAFernandez-OrtegaJF2004Fatal pulmonary embolism after knee arthroscopyAm J Sports Med32525814977685
  • NurmohamedMTRosendaalFRBullerHR1992Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysisLancet34015261352573
  • ObermostererASchippingerGLippRW1999Thromboembolic events following arthroscopic knee sugeryJAMA28243110442657
  • OstergaardPMatzschTBergqvistD1989Trans placental passage of a low molecular weight heparin as compared to standard heparinTromb Haem62515
  • PalmerAJKoppenhagenKKirchhofB1997Efficacy and safety of low molecular weight heparin, unfractioned heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomized clinical trialsHaemostasis2775849212355
  • PiniMTagliaferriAManottiC1989Low molecular weight heparin (Alfa LMWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fracturesInt Angiol813492556484
  • PlanesAVochelleNMazasF1988Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacementThromb Haemost60407102853459
  • PoulsenKABorrisLCLassenMR1993Thromboembolic complications after arthroscopy of the kneeArthroscopy957037506548
  • Prime Care Study Investigators Group2005Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE studyIndian Heart J576485416521631
  • PrejbeanuRVermesanHDragulescuSI2007Thromboembolic risk after knee endoprosthesisEur Rev Med Pharmacol Sci1129730018074938
  • RaskobGEHirshJ2003Controversies in timing of the first doses of anticoagulant prophylaxis against thromboembolism after major orthopaedic surgeryChest124379S85S14668421
  • SamamaCMVrayMBarrèJ2002Exteded venous thromboembolism prophylaxix after total hip replacement: a comparison of low-molecular weight heparin with oral anticoagulantArch Intern Med1622191612390061
  • SchippingerGWirnsbergerGHObernostererABabinskiK1998Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patientsActa Orthop Scand6914469602771
  • SimoniGLucertiniGDecianF1993Low molecular weight heparins: therapeutic insight in peripheral arterial occlusive diseaseClin Trials Metaanal2813745
  • StrebelNPrinsMAgnelliG2002Preoperative or postoperative start of prophylaxis for venous thromboebolism with low-molecular weight heparin in elective hip sugery?Arch Int Med1621451612090880
  • StringerMDSteadmanCAHedgesAR1989Deep vein thrombosis after elective knee surgery. An incidence study in 312 patientsJ Bone Joint Surg Br7149272785998
  • ValleISolaGOrigoneA1988Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosisCurr Med Res Opin118062851413
  • VerardiSCascianiCUNicoraE1988A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosisInt Angiol719242850322
  • VerardiSCorteseFBaroniB1989Deep vein thombosis prevention in surgical patients: effectiveness and safety of a new low molecular weight heparinCurr Ther Res4636672
  • VerhaegeR2005Extended prophylaxis of venous thrombolism in major orthopaedic surgeryActa Orthop Belg71255916035696
  • WangX-KZhangYYangC-M2006Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarctionClin Drug Invest263419
  • WhiteRHRomanoPSZhouH1998Incidence and time of thromboembolic outcomes following hip or knee arthroplastyArch Intern Med1581525319679793
  • WilliamsJSJrHulstynMJFadalePD1995Incidence of deep vein thrombosis after arthroscopic knee surgery: a prospective studyArthroscopy1170158679032
  • WirthTSchneiderBMisselwitzF2001Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized, controlled trialArthroscopy17393911288011